Lessee, Operating Lease, Liability, to be Paid, Year Three of Cullinan Therapeutics, Inc. from 31 Mar 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Cullinan Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Mar 2021 to 31 Dec 2025.
  • Cullinan Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2025 was $906,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Cullinan Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $906,000 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q4 2023 $872,000 -$589,000 -40% 31 Dec 2023 10-K 14 Mar 2024 2023 FY
Q3 2023 $872,000 -$589,000 -40% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $872,000 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $872,000 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,461,000 +$1,148,000 +367% 31 Dec 2022 10-K 09 Mar 2023 2022 FY
Q3 2022 $1,461,000 +$1,148,000 +367% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q4 2021 $313,000 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $313,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $312,850,000 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $313,000 31 Mar 2021 10-Q 14 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.